Envision Mammography Platform
Hologic, Inc. · Decision date Nov 24, 2025
What did the FDA approve?
FDA records P080003/S011 as a supplement to PMA P080003, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Nov 24, 2025.
FDA approval order statement
Approval for a manufacturing site located at Hologic, Inc., 600 Technology Drive, Newark, DE 19702-2463.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Radiology
- Decision date
- Nov 24, 2025
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P080003/S011
- Regulatory pathway
- PMA supplement
- Applicant
- Hologic, Inc.
- Product code
- OTE
- Decision code
- APPR
- Decision date
- Nov 24, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Digital breast tomosynthesis.
- Applicant
- Hologic, Inc.
- Product code
- OTE
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P080003/S011 received
Application receipt date recorded by FDA.
P080003/S011 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P080003. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code OTE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MAMMOMAT B.brilliant with Tomosynthesis OptionP140011/S009 | Siemens Medical Solutions USA, Inc. | PMA supplement | Jul 1, 2026 | FDA |
Senographe Pristina 3DP130020/S005 | GE Healthcare | PMA supplement | Nov 21, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hologic, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 35 Crosby Dr., Bedford, MA, 01730
Sources and methodology
- Original FDA record: P080003/S011
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
